Source:http://linkedlifedata.com/resource/pubmed/id/17989707
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-1-22
|
pubmed:abstractText |
Adoptive transfer of CD4+CD25+ regulatory T cells has been shown to have therapeutic effects in experimental graft-vs-host disease (GVHD) models. Chemokines play an important role in the recruitment of alloreactive donor T cells into target organs during GVHD. In this study, we investigated the effectiveness of targeted delivery of CD4+CD25+ regulatory T cells via a transfected chemokine receptor on reduction of organ damage during acute GVHD. High levels of expression of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and their receptor CXCR3 were observed in the liver, lung and intestine of GVHD-induced recipient mice. Recipient mice that had undergone transfer of CD4+CD25+Foxp3+ CXCR3-transfected T cells (CXCR3-Treg cells) showed significant amelioration of GVHD changes in the liver, lung and intestine in comparison with recipient mice that had received CD4+CD25+Foxp3+ T cells (Treg cells) or naturally occurring CD4+CD25+ regulatory T cells. This was due to more pronounced migration of CXCR3-Treg cells and their localization for a longer time in Th1-associated chemokine-expressing organs, resulting in stronger suppressive activity. We succeeded in preparing chemokine receptor-expressing Treg cells and demonstrated their ability to ameliorate disease progression upon accumulation in target organs. This method may provide a new therapeutic approach for organ damage in acute GVHD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1476-5462
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171-82
|
pubmed:meshHeading |
pubmed-meshheading:17989707-Adoptive Transfer,
pubmed-meshheading:17989707-Animals,
pubmed-meshheading:17989707-Bone Marrow Transplantation,
pubmed-meshheading:17989707-Female,
pubmed-meshheading:17989707-Forkhead Transcription Factors,
pubmed-meshheading:17989707-Gene Therapy,
pubmed-meshheading:17989707-Genetic Vectors,
pubmed-meshheading:17989707-Graft vs Host Disease,
pubmed-meshheading:17989707-Intestines,
pubmed-meshheading:17989707-Liver,
pubmed-meshheading:17989707-Lung,
pubmed-meshheading:17989707-Mice,
pubmed-meshheading:17989707-Mice, Inbred C57BL,
pubmed-meshheading:17989707-Mice, Inbred DBA,
pubmed-meshheading:17989707-Models, Animal,
pubmed-meshheading:17989707-Receptors, CXCR3,
pubmed-meshheading:17989707-Retroviridae,
pubmed-meshheading:17989707-T-Lymphocytes, Regulatory
|
pubmed:year |
2008
|
pubmed:articleTitle |
Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
|
pubmed:affiliation |
Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Ehime, Japan. hitoshih@m.ehime-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|